Transforming iron deficiency diagnostics from acute to preventive

iCheck ID.A is an innovative device designed for the pointof-care screening of iron deficiency and associated anemia.

iCheck ID.A simultaneously measures zinc protoporphyrin and hemoglobin (Hb) in a drop of blood without any chemicals or sample processing.

Zinc protoporphyrin (ZnPP) is an established iron deficiency marker, while hemoglobin is the most used parameter in diagnosing anemia.

Iron deficiency and anemia persist due to suboptimal diagnostics

Diagnosing anemia and its cause is a complex pathway, with generic point of care tests that require multiple laboratory follow-up tests in plasma to identify the cause.
Iron deficiency without anemia cannot be detected at point-of-care and therefore often remains undiagnosed, leading to blanket ineffective treatment, low clinical visibility, and low preventive screening.

Anemia affects one in four people globally

iCheck ID.A prototypes have demonstrated clinical utility in the field

2020

Internal feasibility study demonstrated that laboratory-prototype delivers comparable measurement of Hb and ZnPP in whole blood samples to HemoControl (EKF Diagnostics) for Hb, and to HPLC for ZnPP.

2021 - 2022

Field and laboratory trials with functional prototypes demonstrated clinical utility in differentiating ID with and without anemia at point of care in finger prick blood.

Development of iCheck ID.A proves to be highly anticipated innovation as confirmed by over 20 letters of interest and support from major stakeholders including WHO.
iCheck ID.A wins a prestigious and highly competitive Seal of Excellence during EIC Accelerator under Horizon Europe.

2023 - 2026

BioAnalyt is now in the process of developing a technical prototype that meets EU IVDR requirements enabling robust, reproducible, and clinically reliable ID/IDA diagnosis.
This prototype integrates a multi-modal sensing approach combining multiplexed spectral analysis of fluorometric and absorption information. A machine learning based algorithm is applied, providing advanced in-depth analysis of background and sample information. The combination of these technological modalities enables further metabolic and inflammatory parameters to be targeted.

Transforming iron deficiency diagnostics from acute to preventive

Iron deficiency and anemia persist due to suboptimal diagnostics

1.74 billion people suffering from anemia

€43 billion in GDP losses each year

Anemia affects one in four people globally

Iron deficiency is the cause of 50% anemia cases globally

Iron deficiency develops before anemia and is 2x as prevalent as anemia

It doubles risk of maternal and perinatal death for 32 million pregnant women globally, causing 700,000 deaths

It causes 2x to 3x increased risk of mortality during or after surgery for over 230 million major surgeries globally, leading to 500,000 deaths per year

iCheck ID.A prototypes have demonstrated clinical utility in the field

2020

2021 - 2022

2023 - 2026

We welcome partners and investors to speed up the delivery of our innovation to the market

iCheck ID.A

Women‘s Health

213M

Hospitals

273M

Blood Donation

118M

3 billion tests per year

Advisory board

Valerie Soulier

Marketing Strategy

Prof. Dr. P. Meybohm

Surgery&Hospitals

Dr. A. Raabe

Business Models

Dr. M. Stefanovic

Financing

Dipl.-Ing. F. von Kuenheim

Investment

Dr. R. Lange

IVD Market

Our Funding